JYNT

$8.47

Market ClosedAs of Mar 17, 8:00 PM UTC

The Joint Corp.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$8.47
Potential Upside
5%
Whystock Fair Value$8.89
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Care Facilities

The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor mana...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$125.92M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.28
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-1.50%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.81

Recent News

Moby
Mar 13, 2026

The Joint Corp. Q4 2025 Earnings Call Summary

Moby summary of The Joint Corp.'s Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
GuruFocus.com
Mar 13, 2026

The Joint Corp (JYNT) Q4 2025 Earnings Call Highlights: Strategic Refranchising and Marketing ...

The Joint Corp (JYNT) reports revenue growth and strategic shifts, despite facing hurdles in patient acquisition and sales comps.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 13, 2026

Joint Q4 Earnings Call Highlights

Joint (NASDAQ:JYNT) reported fourth-quarter and full-year 2025 results while outlining progress on its “Joint 2.0” transformation plan, which management said is on track to be completed by the end of 2026. On the company’s earnings call, President and CEO Sanjiv Razdan and CFO Scott Bowman highlight

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Motley Fool
Mar 12, 2026

The Joint (JYNT) Q4 2025 Earnings Call Transcript

Joining us on the call today are President and CEO, Sanjiv Razdan, and CFO, Scott Bowman. This afternoon, The Joint Corp. issued a press release for the fourth quarter and full year ended 12/31/2025. As provided on Slide 2, please be advised that today’s discussion, including any financial and related guidance to be provided, consists of forward-looking statements as defined by securities laws.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 12, 2026

The Joint Corp. (JYNT) Beats Q4 Earnings and Revenue Estimates

The Joint (JYNT) delivered earnings and revenue surprises of +33.33% and +10.59%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.